Extensive genetic and epigenetic profiling of systemic metabolism to understand and prevent cardiometabolic diseases
Bidragets beskrivning
Cardiometabolic diseases, such as coronary heart disease, stroke, and diabetes, are the leading causes of death and disability in Finland and worldwide. To be able to develop novel methods for treatment and prevention, we need to understand the complex molecular pathways involved and identify biomarkers that play a causal role in the disease aetiology. Current risk evaluation strategies are focused on measuring blood cholesterol and triglyceride levels, and lipid-lowering medications function on the same lipids. Lipid metabolism, however, is a complex system, and the detailed understanding of the fine-grained molecular mechanisms is insufficient. By combining genetic analyses with extensive biomarker data covering ~1000 lipoprotein, lipid, and other metabolic measures, this project aims to deliver a detailed description of molecular pathways involved in systemic metabolism and to identify novel causal biomarkers that could serve as targets of new therapeutics.
Visa merStartår
2021
Slutår
2025
Beviljade finansiering
Finansiär
Finlands Akademi
Typ av finansiering
Forskardoktorer
Utlysning
Övriga uppgifter
Finansieringsbeslutets nummer
338229
Vetenskapsområden
Genetik, utvecklingsbiologi, fysiologi
Forskningsområden
Perinnöllisyystiede
Identifierade teman
public health, occupational health